TY  - JOUR
AU  - López-Corral, Lucia
AU  - Caballero-Velázquez, Teresa
AU  - López-Godino, Oriana
AU  - Rosiñol, Laura
AU  - Pérez-Vicente, Sabina
AU  - Fernandez-Avilés, Francesc
AU  - Krsnik, Isabel
AU  - Morillo, Daniel
AU  - Heras, Inmaculada
AU  - Morgades, Mireia
AU  - Rifon, Jose J
AU  - Sampol, Antonia
AU  - Iniesta, Francisca
AU  - Ocio, Enrique-María
AU  - Martin, Jesús
AU  - Rovira, Montserrat
AU  - Cabero, Martín
AU  - Castilla-Llorente, Cristina
AU  - Ribera, Josep-María
AU  - Torres-Juan, Marta
AU  - Moraleda, Jose María
AU  - Martinez, Carmen
AU  - Vázquez, Alejandro
AU  - Gutierrez, Gonzalo
AU  - Caballero, Dolores
AU  - San Miguel, Jesús F
AU  - Mateos, María-Victoria
AU  - Pérez-Simón, Jose Antonio
PY  - 2019
DO  - 10.1016/j.bbmt.2019.04.026
UR  - http://hdl.handle.net/10668/13914
T2  - Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
AB  - Multiple myeloma (MM) remains as an incurable disease and, although allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative approach, most patients ultimately relapse, and their treatment remains challenging. Because...
LA  - en
KW  - Allo-HSCT
KW  - Allogeneic hematopoietic stem cell transplantation
KW  - Immunomodulatory drug
KW  - Multiple myeloma
KW  - Proteasome inhibitor
KW  - Adult
KW  - Aged
KW  - Allografts
KW  - Disease-Free Survival
KW  - Female
KW  - Follow-Up Studies
KW  - Graft vs Host Disease
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Immunologic Factors
KW  - Incidence
KW  - Male
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - Proteasome Inhibitors
KW  - Recurrence
KW  - Retrospective Studies
KW  - Spain
KW  - Survival Rate
TI  - Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma.
TY  - research article
VL  - 25
ER  -